MoH withdraws Augmentin 250 mg from market

posted on 29/08/2012: 703 views

The Ministry of Health (MoH) has ordered the withdrawal of Batch No. 517999 of Augmentin 250 mg for children, made by GlaxoSmithKline (GSK), from all public and private hospitals, medical centres, clinics and pharmacies as tiny plastic pieces could mix with the medicine due to a manufacturing failure.

In a statement issued yesterday, MoH's Assistant Undersecretary for Medical Practices and Licensing Dr Amin Hussein Al Amiri said the circular issued by the Ministry also bans further imports of the same batch and orders GSK to provide a detailed report on the withdrawal of the drug and to provide enough quantities to make up for any possible shortage.

All other batches of the said product are safe for human consumption and any side effects which might develop should however be reported online to the ministry, the official said. – Emirates News Agency, WAM

RELATED ARTICLES

20 May 2013	DHA’s strategy will promote Dubai as health tourism hub
07 May 2013	No coronavirus cases in the UAE, Dubai Health Authority says
27 April 2013	European Commission commends Mohammed bin Zayed's
27 April 2013	Global Leaders support new six-year plan to deliver a polio-free world by 2018
27 April 2013	Bill Gates on polio: Zero is the number we need to get to